Fig. 6From: Myometrial oxidative stress drives MED12 mutations in leiomyomaDuplex sequencing analysis of MED12 exon 2 mutations in primary myometrial cells with PQ treatment and native myometrial tissue. a–b. Heatmap illustrated the accurate distribution of MED12 mutation rates in exon 2 detected by duplex sequencing analysis in 16 myometrial samples with long-term PQ treatment (a) or with vehicle controls (b)Back to article page